Safety, tolerability, pharmacodynamics, and pharmacokinetics of rivaroxaban– an oral, direct Factor Xa inhibitor–are not affected by aspirin - Kubitza, D; Becka, M; Mueck, W (J Clin Pharmacol, 2006)
et al.